Lymphatic mapping and sentinel node biopsy in the patient with breast cancer

Journal of the American Medical Association

Volumn 276, Issue 22, 1996, Pages 1818-1822

  Albertini, John J ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TECHNETIUM SULFUR COLLOID TC 99M;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER STAGING; CLINICAL PROTOCOL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE BIOPSY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHOGRAPHY; MAJOR CLINICAL STUDY; NEEDLE BIOPSY; PRIORITY JOURNAL; VITAL STAIN;

AXILLA; BIOPSY; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; COLORING AGENTS; FEMALE; HUMANS; INTRAOPERATIVE PERIOD; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; PROBABILITY; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TECHNETIUM TC 99M SULFUR COLLOID;

EID: 10544235697     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.276.22.1818     Document Type: Article

References (41)

1. Haagensen CD. Treatment of curable carcinoma of the breast. Int J Radial Oncol Biol Phys. 1977;2:975-980.
2. Bonadonna G. Karnofsky Memorial Lecture: conceptual and practical advances in the management of breast cancer. J Clin Oncol. 1989;7:1380-1397.
3. Batch CM, Singletary ES, Bland KI. Clinical decision-making in early breast cancer. Ann Surg. 1993217:207-225.
4. Frazier TG, Copeland EM, Gallaher HS, Paulus DD, White EC. Prognosis and treatment in minimal breast cancer. Am J Surg. 1977;133:697-701.
5. Silverstein MJ, Rosser RJ, Gierson ED, et al. Axillary lymph node dissection for intraductal carcinoma: is it indicated? Cancer. 1987;59:1819-1824.
6. Silverstein MJ, Gierson ED, Waisman JR, Senofsky GM, Colburn WS, Gamagami P. Axillary lymph node dissection for Tla breast carcinoma: is it indicated? Cancer. 1994;73:664-667.
7. Baker LH. Breast Cancer Detection Demonstration Project: five-year summary report. CA Cancer J Clin. 1982;32:194-225.
8. Dewar JA, Sarrarin D, Benhamou E, et al. Management of the axilla in conservatively treated breast cancer. 592 patients treated at Institut Gustave-Roussy. Int J Radiat Oncol Biol Phys. 1987;13:475-481.
9. Veronesi U, Rilke F, Luini A, et al. Distribution of axillary nodal metastases by level of invasion: an analysis of 539 cases. Cancer. 1987;59:682-687.
10. Morion DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg. 1992;127:392-399.
11. Reintgen DS, Cruse CW, Herman C, et al. An orderly progression of melanoma nodal metastases. Ann Surg. 1994;220:759-767.
12. Nicosia SV, Horowitz SA, Williams JA, Ku NN, Reintgen DS, Cox C. Fine needle aspiration biopsy of palpable breast lesions: review and statistical analysis of 1,311 cases. Acta Cytol. 1991;35:609-610.
13. Wanebo HJ, Feldman PS, Wilhelm MC, Covell JL, Binns RL. Fine needle aspiration cytology in lieu of open biopsy in management of primary breast cancer. Ann Surg. 1984;199:569-579.
14. Nicastri GR, Reed WP, Dziura BR. The accuracy of malignant diagnoses established by fine needle aspiration cytologie procedures of mammary masses. Surg Gynecol Obslet. 1991;172:457-460.
15. Hollander M, Wolfe DA. Nonparametric Statistical Methods. New York, NY: John Wiley & Sons Inc; 1973.
16. Lin PP, Allison DC, Wainstock J, et al. Impact of axillary node dissection on the therapy of breast cancer patients. J Clin Oncol. 1993;11:1536-1544.
17. Ivens D, Hoe AL, Podd TJ, Hamilton CR,Taylor I, Royle GT. Assessment of morbidity from complete axillary dissection. Br J Cancer. 1992;66:136-138.
18. Recht A, Houlihan MJ. Axillary lymph nodes and breast cancer: a review. Cancer. 1995;76:1491-1512.
19. Morrow M. Role of axillary dissection in breast cancer management. Ann Surg Oncol. 1996;3:233-234.
20. Baxter N, McCready D, Chapman JA, et al. Clinical behavior of untreated axillary nodes after local treatment for primary cancer. Ann Surg Oncol. 1996;3:235-240.
21. Cady E. The need to reexamine axillary lymph node dissection in invasive breast cancer. Cancer. 1994;73:505-508.
22. Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg. 1994;220:391-401.
23. Ross M, Reinigen DS, Balch C. Selective lymphadenectomy: emerging role for lymphatic mapping and sentinel node biopsy in the management of early stage melanoma. Semin Surg Oncol. 1993;9:219-223.
24. Krag DN, Meijer SJ, Weaver DL, et al. Minimalaccess surgery for staging of malignant melanoma. Arch Surg. 1995;130:654-660.
25. Thompson JF, McCarthy WH, Robinson E, et al. Sentinel lymph node biopsy in 102 patients with clinical stage 1 melanoma undergoing elective lymph node dissection. Melanoma Res. 1995;5:255-260.
26. Nathanson SD, Nelson L, Karvelis KG. Rates of flow of technetium 99m-labeled human serum albumin from peripheral injection sites to sentinel lymph nodes. Ann Surg Oncol. 1996;3:329-335.
27. Krag DN, Weaver DL, Alex JC, Fairbank JT. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol. 1993;2:335-340.
28. Gardner B, Feldman J. Are positive axillary nodes in breast cancer markers for incurable disease? Ann Surg. 1993;218:270-278.
29. Noguchi S, Aihara T, Motomura K, Inaji H, Imaoka S, Koyama H. Detection of breast cancer micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction. Am J Pathol. 1996;2:649-656.
30. Schoenfeld A, Lugmani Y, Smith D, et al. Detection of breast cancer micrometastases in axillary lymph nodes by using polymerase chain reaction. Cancer Res. 1994;54:2986-2990.
31. International (Ludwig) Breast Cancer Study Group. Prognostic importance of occult axillary lymph node micrometastases from breast cancers. Lancet. 1990;335:1565-1568.
32. Trojani M, de Mascarel I, Bonichon F, Coindre JM, Delsol G. Micrometastases to axillary lymph nodes from carcinoma of the breast: detection by immunohistochemistry and prognostic significance. Br J Cancer. 1987;55:303-306.
33. Springall SJ, Rytina EEC, Millis RR. Incidence and significance of micrometastases in axillary lymph nodes detected by immunohistochemical techniques. J Pathol. 1990;160:174.
34. Hainsworth PJ, Tjandra JJ, StillweU RG, et al. Detection and significance of occult metastases in node negative breast cancer. Br J Surg. 1993;80:459-463.
35. Wang X, Heller R, VanVoorhis N, et al. Detection of submicroscopic lymph node metastases with polymerase chain reaction in patients with malignant melanoma. Ann Surg. 1994;220:768-774.
36. Fields KK, Elfenbein GJ, Trudeau WL, Perkins JB, Janssen WE, Moscinski LC. Clinical significance of bone marrow metastases as detected using the polymerase chain reaction in patients with breast cancer undergoing high-dose chemotherapy and autologous bone marrow transplantation. J Clin Oncol 1996;6:1868-1876.
37. Greenson JK, Isenhart CE, Rice R, Mojzisik C, Houchens D, Martin EW Jr. Identification of occult micrometastases in pericolic lymph nodes of Duke's B colorectal cancer patients using monoclonal antibodies against cytokeratin and CC49: correlation with long-term survival. Cancer. 1994;73:563-569.
38. Moss TJ, Reynolds CP, Sather HN, Romansky SG, Hammond GD, Seeger RC. Prognostic value of immunocytologic detection of bone marrow metastases in neuroblastoma. N Engl J Med. 1991;324:219-226.
39. Moreno JG, Crose CM, Fisher R, et al. Detection of hematogenous micrometastases in patients with prostate cancer. Cancer Res. 1992;52:6110-6112.
40. Maehara Y, Oshiro T, Endo K, et al. Clinical significance of occult micrometastases in lymph nodes from patients with early gastric cancer who died of recurrence. Surgery. 1996;119:397-402.
41. Albertini JJ, Cruse CW, Rapaport D, et al. Intraoperative radio-lympho-scintigraphy improves sentinel node identification for patients with melanoma. Ann Surg. 1996;223:217-224.